Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial - Quiz - MDSpire

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial

  • By

  • Nina Magnolo

  • Jennifer Soung

  • John Frew

  • Antonio Costanzo

  • Hiram Ruiz-Santiago

  • Kilian Eyerich

  • Mar Llamas-Velasco

  • Michael Bukhalo

  • Raja K. Sivamani

  • Angela Moore

  • Tianshuang Wu

  • Jiaheng Xie

  • Manish Patel

  • Doug Ashley

  • Blair Kaplan

  • Vassilis Stakias

  • Ramon Espaillat

  • Richard B. Warren

  • May 17, 2026

Share

Original Source(s)

Related Content